Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin

Blood Res. 2015 Dec;50(4):254-6. doi: 10.5045/br.2015.50.4.254. Epub 2015 Dec 21.

Authors

Hee Kyung Kim¹, Seong Mi Moon¹, Ji Hoon Moon¹, Jee Eun Park¹, Seonggyu Byeon¹, Won Seog Kim¹

Affiliation

¹ Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

No abstract available

Publication types

Case Reports